Financials

  • Market Capitalization 10.62 B
  • Employee 507
  • Founded 2013
  • CEO N/A
  • Website www.vaxcyte.com
  • Headquarter Delaware, United States
  • FIGI BBG009PHHPL8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-8.2
Rapporto prezzo/fatturato
—

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
834
IBRX
ImmunityBio, Inc. - Common Stock
10.51 USD+6.05%-2.32%+33.21%+341.60%11.14 B USD
847
MDGL
Madrigal Pharmaceuticals, Inc. - Common Stock
471.75 USD-1.08%-6.58%-12.64%+11.36%10.90 B USD
859
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
54.80 USD-0.16%-4.04%-17.59%+4.68%10.61 B USD
890
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
79.78 USD+1.31%+5.02%+2.43%+101.24%10.15 B USD

Notizie